Skip to main content
Fig. 1 | Health and Quality of Life Outcomes

Fig. 1

From: Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA

Fig. 1

a Mean (SD), and b mean (95% CI) change in EQ-5D VAS scores (FAS). a) Time points: at injection cycle baseline and 4 weeks post-injection in each injection cycle and at the end of injection cycle 3. b) Time points: from the study baseline to 4 weeks post-injection in each injection cycle and to the end of injection cycle 3. Positive values indicate improvement. *p < 0.0001 compared with the study baseline visit in injection cycle 1, Student’s t-test for paired samples. CI, confidence interval; EQ-5D, EuroQol 5-dimensions questionnaire, three-level; FAS, full analysis set; SD, standard deviation; VAS, visual analog scale

Back to article page